Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

07/16/2014 | 08:45pm US/Eastern

By a News Reporter-Staff News Editor at Cancer Weekly -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with Merck KGaA's strategic approach in personalized medicine, the aim is to develop a patient stratifying diagnostic test that can be used in multiple cancer indications. Merck KGaA, which is actively investing in innovation in the CDx field through a number of partnerships, will leverage Ventana's global leadership position in cancer diagnostics and vast expertise in CDx to achieve new levels of diagnostic clarity for the investigated target. As part of the agreement, Ventana will develop and validate the CDx and ensure its readiness, availability, and adherence to FDA and other health authority standards for future clinical trials (see also Ventana Medical Systems, Inc.).

"Tailoring therapies based on a patient's specific genes, proteins or tissue environment is a key expansion area for oncology. We are very pleased to partner with Merck in Darmstadt, Germany to co-develop a CDx that will play a vital role in improving the quality of care for cancer patients," said Doug Ward, Vice President, Companion Diagnostics, Ventana Medical Systems, Inc. "Ventana is committed to continuing to provide the industry's gold standard in biomarker detection using our proprietary assays as the basis for novel companion diagnostic tests."

This pharma partnership is one of several currently underway where the Ventana Companion Diagnostics team is delivering patient stratifying diagnostic tests that help identify those patients who are most likely to benefit from specific treatments. In addition to the biopharmaceutical division of Merck KGaA, Ventana has announced partnerships with Bayer, Pfizer, Boehringer Ingelheim, Takeda's Millennium unit, Genmab, Incyte, MedImmune and more. Since 2002, the company has worked with more than 45 biopharmaceutical partners and is currently engaged in more than 180 collaborative projects to develop and commercialize companion diagnostics globally.

Companion diagnostics (CDx) are tests designed to confirm the presence of a specific biomarker to assist physicians in selecting effective therapies for their patients, based on the individual characteristics of each person. Incorporating a companion diagnostic strategy into a drug development program may expedite the drug approval process and help generate more effective treatments with improved safety profiles for patients.

Keywords for this news article include: Cancer, Genetics, Oncology, Ventana Medical Systems Inc.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

(c) 2014 NewsRx LLC

Latest news
Date Title
<1m ago UNITED MICROELECTRONICS : Patent Application Titled "Method and Device for Pulse Width Estimation" Published Online
<1m ago Patent Application Titled "Flexible Substrate, Flexible Display Device, and Method for Manufacturing Flexible Display Device" Published Online
<1m ago ALTERA : Patent Issued for Apparatus and Methods for Equalizer Adaptation
<1m ago OMRON : Patent Issued for Acoustic Transducer, and Microphone Using the Acoustic Transducer
<1m ago Patent Application Titled "Fluid Draining and Dispensing System for Household Appliances and Fluid Dispensing Tube for Household Appliances"...
<1m ago Patent Application Titled "Gas Circuit Breaker" Published Online
<1m ago LG ELECTRONICS : Patent Application Titled "Control Panel, Control Method Thereof and Clothes Treating Apparatus Having the Same" Published Online
<1m ago MACRONIX : Patent Issued for 3D Semiconductor Structure and Manufacturing Method
<1m ago Patent Application Titled "Display Device and Method of Driving the Same" Published Online
<1m ago Patent Application Titled "High-Speed Signal Transmission Cable" Published Online
Latest news
Advertisement
Hot News 
WILLBROS : Harwood Feffer LLP : Announces Investigation of Willbros Group, Inc.
XEROX : Patent Issued for Deletion of Unwanted Reply Messages in E-Mail Printing
PEREGRINE SEMICONDUCTOR : Enables a Dual-Band Architecture for DOCSIS 3.1 Devices
HEALTH INSURANCE INNOVATIONS : Distributor of PPACA-free products posts big sales gains
BOEING : China's Comac Start to Make Jet Fuel from Used Cooking Oil
Most Read News
1d ago TERADYNE : beats Street 3Q forecasts
1d ago ATMEL : Patent Issued for Apparatus and Method for Increasing the Quantity of Discrete Electronic Components in an Integrated Circuit Package
1d ago EXELON : ICC Approves ComEd’s Grand Prairie Gateway Project
1d ago AT&T revenue misses forecasts as more customers bring own phones
1d ago NORTHFIELD BANCORP : Announces Third Quarter 2014 Results
Most recommended articles
10m ago China flash HSBC PMI edges up in October but no indication of turnaround yet
10m ago China forex regulator says not worried about capital outflows
12m agoDJSoft New Zealand Inflation Data Push Out Rate Rise Expectations
14m agoDJHSBC October Preliminary China Manufacturing PMI Rises to 50.4 -- Update
17m ago USD/JPY Short Body Candles Suggest Caution Persists Near 107.00
Dynamic quotes  
ON
| OFF